FdaApplication
NDA 204078
Identifiers
- fda_app_no: NDA204078
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | NDA |
| approval_date | 2013-05-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BLOXIVERZ | NEOSTIGMINE METHYLSULFATE | 5MG/10ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
| BLOXIVERZ | NEOSTIGMINE METHYLSULFATE | 5MG/5ML (1MG/ML) | SOLUTION;INTRAVENOUS |
| BLOXIVERZ | NEOSTIGMINE METHYLSULFATE | 10MG/10ML (1MG/ML) | SOLUTION;INTRAVENOUS |
3 products